University of Texas MD Anderson Cancer Center

Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer (2022) Peddi PF, Fasching P, Liu D, Quinaux E, Robert NJ, Valero V, Crown J, et al. Journal article Review and consensus recommendations on clinical APT-weighted imaging approaches at 3T: Application to brain tumors (2022) Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, Bachert P, et al. Journal article, Review article IBCN Seminar Series 2021: Circulating tumor DNA in bladder cancer (2022) Christensen E, Wyatt AW, Galsky MD, Grivas P, Seiler R, Nawroth R, Goebell P, et al. Journal article, Review article Biology of BCG response in non-muscle invasive bladder cancer - 2021 IBCN Updates Part III (2022) Reike MJ, Ingersoll MA, Müller DC, Zuiverloon TC, Strandgaard T, Kamat AM, Williams SB, et al. Journal article, Review article Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022) Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al. Journal article AAPM Task Group Report 290: Respiratory motion management for particle therapy (2022) Li H, Dong L, Bert C, Chang J, Flampouri S, Jee KW, Lin L, et al. Journal article Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients (2021) Fuchs TL, Maclean F, Turchini J, Vargas AC, Bhattarai S, Agaimy A, Hartmann A, et al. Journal article Lu-177-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial (2021) Strosberg JR, Caplin ME, Kunz PL, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, et al. Journal article Chronic occupational mold exposure drives expansion of aspergillus-reactive type 1 and type 2 t-helper cell responses (2021) Lauruschkat CD, Etter S, Schnack E, Ebel F, Schaeuble S, Page L, Rumens D, et al. Journal article The Phase 3 NETTER-1 Study of [Lu-177]Lu-DOTA-TATE in Patients with Midgut Neuroendocrine Tumours: Final Overall Survival and Long-Term Renal Safety (2021) Kunz P, Caplin ME, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, et al. Conference contribution